These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 21261636)

  • 1. Bioavailability of resveratrol.
    Walle T
    Ann N Y Acad Sci; 2011 Jan; 1215():9-15. PubMed ID: 21261636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and bioavailability of trans-resveratrol.
    Wenzel E; Somoza V
    Mol Nutr Food Res; 2005 May; 49(5):472-81. PubMed ID: 15779070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High absorption but very low bioavailability of oral resveratrol in humans.
    Walle T; Hsieh F; DeLegge MH; Oatis JE; Walle UK
    Drug Metab Dispos; 2004 Dec; 32(12):1377-82. PubMed ID: 15333514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
    Lin HS; Ho PC
    J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol bioavailability and toxicity in humans.
    Cottart CH; Nivet-Antoine V; Laguillier-Morizot C; Beaudeux JL
    Mol Nutr Food Res; 2010 Jan; 54(1):7-16. PubMed ID: 20013887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method.
    Rotches-Ribalta M; Urpi-Sarda M; Llorach R; Boto-Ordoñez M; Jauregui O; Chiva-Blanch G; Perez-Garcia L; Jaeger W; Guillen M; Corella D; Tinahones FJ; Estruch R; Andres-Lacueva C
    J Chromatogr A; 2012 Nov; 1265():105-13. PubMed ID: 23089514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of resveratrol: What formulation solutions to bioavailability limitations?
    Amri A; Chaumeil JC; Sfar S; Charrueau C
    J Control Release; 2012 Mar; 158(2):182-93. PubMed ID: 21978644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent absorption and metabolism of trans-polydatin in rats.
    Zhou S; Yang R; Teng Z; Zhang B; Hu Y; Yang Z; Huan M; Zhang X; Mei Q
    J Agric Food Chem; 2009 Jun; 57(11):4572-9. PubMed ID: 19397265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of skin-absorbed resveratrol into its glucuronized form in mouse skin.
    Murakami I; Chaleckis R; Pluskal T; Ito K; Hori K; Ebe M; Yanagida M; Kondoh H
    PLoS One; 2014; 9(12):e115359. PubMed ID: 25506824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol is absorbed in the small intestine as resveratrol glucuronide.
    Kuhnle G; Spencer JP; Chowrimootoo G; Schroeter H; Debnam ES; Srai SK; Rice-Evans C; Hahn U
    Biochem Biophys Res Commun; 2000 May; 272(1):212-7. PubMed ID: 10872829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of trans-resveratrol from red wine in humans.
    Vitaglione P; Sforza S; Galaverna G; Ghidini C; Caporaso N; Vescovi PP; Fogliano V; Marchelli R
    Mol Nutr Food Res; 2005 May; 49(5):495-504. PubMed ID: 15830336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma.
    Burkon A; Somoza V
    Mol Nutr Food Res; 2008 May; 52(5):549-57. PubMed ID: 18435437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tissue distribution of resveratrol, emodin and their metabolites after intake of Polygonum cuspidatum in rats.
    Lin SP; Chu PM; Tsai SY; Wu MH; Hou YC
    J Ethnopharmacol; 2012 Dec; 144(3):671-6. PubMed ID: 23069945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of resveratrol bioavailability in the perfused small intestine of the rat.
    Andlauer W; Kolb J; Siebert K; Fürst P
    Drugs Exp Clin Res; 2000; 26(2):47-55. PubMed ID: 10894555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice.
    Meng X; Maliakal P; Lu H; Lee MJ; Yang CS
    J Agric Food Chem; 2004 Feb; 52(4):935-42. PubMed ID: 14969553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of
    Jarosova V; Vesely O; Doskocil I; Tomisova K; Marsik P; Jaimes JD; Smejkal K; Kloucek P; Havlik J
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32106482
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets.
    Rotches-Ribalta M; Andres-Lacueva C; Estruch R; Escribano E; Urpi-Sarda M
    Pharmacol Res; 2012 Nov; 66(5):375-82. PubMed ID: 22906730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after red wine oral administration in rats.
    Bertelli AA; Giovannini L; Stradi R; Urien S; Tillement JP; Bertelli A
    Int J Clin Pharmacol Res; 1996; 16(4-5):77-81. PubMed ID: 9172004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol.
    Chauhan AS
    Ann N Y Acad Sci; 2015 Aug; 1348(1):134-40. PubMed ID: 26173478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.
    Kapetanovic IM; Muzzio M; Huang Z; Thompson TN; McCormick DL
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):593-601. PubMed ID: 21116625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.